This gives us numerous options to ensure successful commercialization of our new genetic products. Our host production systems span a wide range of bacteria and fungi.
In addition, a key advantage of our i-biotech® approach is the concurrent application of our protein production systems with our other technology platforms.
Genencor’s broad range of options gives us a significant competitive advantage in terms of our ability to provide cost-effective production - a challenge that is often more difficult than initial protein discovery.
Top
Print
Mail a colleague about this page
